A Comparison of Early Outcome of Surgical Management of Proximal Humerus Fracture in Adults During COVID-19 Pandemic- A Prospective Cohort Study

NCT ID: NCT06506006

Last Updated: 2024-07-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

78 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-01

Study Completion Date

2022-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to learn the outcome of proximal humerus fracture surgery in patients who had it delayed due to COVID infection and compare it with normal patients with same fracture and treatment. The main question it aims to answer is:

• Do the patients with proximal humerus fracture undergoing delayed fixation secondary to COVID infection have the same outcome as that of the normal patients?

The outcome of patients of both group will be assessed objectively via the standard Neer"s shoulder score and compared using independent variable T test.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Proximal Humerus Surgery in Covid Recovered Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

post COVID

patients with proximal humerus fracture with concommitant COVID postive status receiving delayed treatment

Covid infection

Intervention Type BIOLOGICAL

outcome with and without covid infection

Non COVIID

patients with proximal humerus fracture without concommitant COVID postive status receiving usual treatment

Covid infection

Intervention Type BIOLOGICAL

outcome with and without covid infection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Covid infection

outcome with and without covid infection

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* isolated traumatic proximal humerus fracture (Neer's grading 3 and 4)
* above 18 years of age
* consenting for the study

Exclusion Criteria

* open fractures: Gustilo Grade II and III
* neurovascular compromise.
* neuromuscular disorders.
* injury severity score \>16
* humerus fracture with extension to shaft
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

B.P. Koirala Institute of Health Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

ashbin bhattarai

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

ashbin bhattarai, masters

Role: PRINCIPAL_INVESTIGATOR

National Trauma Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

B.P.Koirala Insitute of Helath Sciences

Dharān, Koshi, Nepal

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Nepal

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

306/077/078-IRC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hip Fracture and COVID-19
NCT04944329 COMPLETED
AI PREDICTION FOR PROXIMAL HUMERAL FRACTURES
NCT06467006 NOT_YET_RECRUITING